Pulmonary Tuberculosis clinical trials

Explore recruiting pulmonary tuberculosis clinical trials.

Recruiting pulmonary tuberculosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pulmonary Tuberculosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Low Intervention, Open, Multicentric, Phase IV Exploratory Clinical Trial to evaluate new biomarkers for the diagnosis and treatment monitoring of tuberculosis

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Phase II study on the safety and efficacy of cysteamine in association with standard tuberculosis therapy for the treatment of patients with pulmonary tuberculosis: a new therapy for tuberculosis directed at the host.

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A study to investigate the pharmacokinetics of a combined oral contraceptive when given alone and in combination with GSK3036656 in female participants of non-childbearing potential aged 18 to 65 years of age

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

A study to investigate the repeat-dose pharmacokinetics of a combined oral contraceptive when given alone and in combination with ganfeborole in female participants of non-childbearing potential.

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

RANDOMIZED, CONTROLLED, OPEN, MULTICENTRIC CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A COMBINATION OF ANTI-TUBERCULOUS DRUGS BASED ON HIGH DOSE RIFAMPICIN, HIGH DOSE MOXIFLOXACIN AND LINEZOLID IN PATIENTS WITH BACILLIFEROUS PULMONARY TUBERCULOSIS (RML-TB).

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis (DRTB-HDT).

Romania

Therapeutic exploratory (Phase II) EU CTIS Study details

Pulmonary Tuberculosis trials by city

Pulmonary Tuberculosis in Toronto Pulmonary Tuberculosis in Vancouver Pulmonary Tuberculosis in Montreal Pulmonary Tuberculosis in Calgary Pulmonary Tuberculosis in Edmonton Pulmonary Tuberculosis in Ottawa Pulmonary Tuberculosis in Winnipeg Pulmonary Tuberculosis in Quebec City Pulmonary Tuberculosis in Hamilton Pulmonary Tuberculosis in Kitchener Pulmonary Tuberculosis in London Pulmonary Tuberculosis in Halifax Pulmonary Tuberculosis in New York Pulmonary Tuberculosis in Los Angeles Pulmonary Tuberculosis in Chicago Pulmonary Tuberculosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease